# US 2021/0277063 A1 · Method for producing cyclized peptide having intramolecular s-s bond

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277063 A1
- Document ID: US20210277063A1
- Status: Published application
- Kind: A1
- Application number: 17/319,346
- Filed: 2021-05-13
- Published: 2021-09-09
- Earliest claimed: 2018-11-16
- Assignees: Ajinomoto Co., Inc.
- Applicants: Ajinomoto Co., Inc.
- Inventors: Daisuke TAKAHASHI; Tatsuji INOMATA; Yuki SHINOHARA
- Web page: https://patentgrep.com/patent/US20210277063A1

## CPC

- C07K 1/1133: {by redox-reactions involving cystein/cystin side chains}
- C07K 7/64: Cyclic peptides containing only normal peptide links
- C07K 1/061: {using protecting groups}
- C07K 1/067: {for sulfur-containing functions}
- C07K 1/107: by chemical modification of precursor peptides
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Cyclized peptides having a crosslinked structure by one or more intramolecular S—S bonds may be prepared by: (1-A) as to a completely protected linear peptide having two or more SH groups as functional groups on the peptide, removing protecting groups of all functional groups other than the protected SH groups in the peptide, (1-B) protecting all SH groups of the linear peptide having two or more SH groups as the functional groups on the peptide by forming a temporary S—S bond, and (2) subjecting the peptide obtained by step (1-A) and step (1-B) to a folding step under oxidation and reduction conditions to obtain the cyclized peptide by re-forming an S—S bond in the peptide molecule.

## Claims

### Claim 1

A method for producing a cyclized peptide, comprising
(1-A) as to a linear peptide having two or more SH groups as functional groups on the peptide, in which all SH groups are protected, an N terminal amino group is optionally protected, and all of a C-terminal carboxy group and other functional groups on the peptide are protected (hereinafter “completely-protected peptide”), a step of removing protecting groups of all functional groups other than the protected SH groups in the peptide,
(1-B) a step of protecting all SH groups of the linear peptide having two or more SH groups as the functional groups on the peptide by forming a temporary S—S bond, and
(2) a step of subjecting the peptide obtained by the above-mentioned step (1-A) and step (1-B), in which two or more SH groups are present as the functional groups on the peptide, all SH groups are protected by formation of a temporary S—S bond, and all protecting groups of other functional groups on the peptide are removed (hereinafter “S-protected peptide”) to a folding step under oxidation and reduction conditions to obtain the cyclized peptide by re-forming an S—S bond in the peptide molecule.

### Claim 2 (depends on 1)

The production method of a cyclized peptide according to claim 1, wherein the protection of all SH groups by forming a temporary S—S bond in step (1-B) is performed by “forming a temporary S—S bond with all SH groups within peptide molecules and/or between peptide molecules” (hereinafter “temporary S—S formation”), or
the protection of all SH groups by forming a temporary S—S bond in step (1-B) is performed by forming a temporary S—S bond with an S-type protecting group.

### Claim 3 (depends on 2)

The production method of a cyclized peptide according to claim 2, wherein the protection of all SH groups by forming a temporary S—S bond in step (1-B) is performed by temporary S—S formation.

### Claim 4 (depends on 3)

The production method of a cyclized peptide according to claim 3, wherein the temporary S—S formation is performed by an iodine treatment or a thallium (III) trifluoroacetate treatment.

### Claim 5

The production method of a cyclized peptide according to claim A, wherein the temporary S—S formation is performed by the iodine treatment.

### Claim 6 (depends on 3)

The production method of a cyclized peptide according to claim 3, wherein the S-protected peptide is obtained by subjecting the completely-protected peptide to temporary S—S formation to obtain a mixture of peptides crosslinked or linked by a temporary S—S bond (hereinafter “temporary S—S formed peptide mixture”) in step (1-B), and
the protecting groups of all functional groups other than the SH group protected by temporary S—S bond formation in the temporary S—S formed peptide mixture are removed in step (1-A).

### Claim 7 (depends on 6)

The production method of a cyclized peptide according to claim 6, wherein the protecting group of the SH group in the completely-protected peptide is a protecting group other than an S-type protecting group.

### Claim 8 (depends on 7)

The production method of a cyclized peptide according to claim 7, wherein the protecting group of the SH group in the completely-protected peptide is a trityl group (Trt group), an acetamidomethyl group (Acm group), a benzyl group (Bzl group), a 4-methylbenzyl group (4-MeBzl group), or a 4-methoxybenzyl group (MBzl group).

### Claim 9 (depends on 6)

The production method of a cyclized peptide according to claim 6, wherein the temporary S—S formation is performed by an iodine treatment or a thallium (III) trifluoroacetate treatment.

### Claim 10 (depends on 9)

The production method of a cyclized peptide according to claim 9, wherein the temporary S—S formation is performed by an iodine treatment.

### Claim 11 (depends on 3)

The production method of a cyclized peptide according to claim 3, wherein the S-protected peptide is obtained by removing the protecting groups of all functional groups other than the SH group of the completely-protected peptide in step (1-A), and then or simultaneously subjecting the deprotected peptide to temporary S—S formation in step (1-B) to obtain a temporary S—S formed peptide mixture.

### Claim 12 (depends on 11)

The production method of a cyclized peptide according to claim 11, wherein the protecting group of the SH group of the completely-protected peptide is a protecting group other than an S-type protecting group.

### Claim 13 (depends on 12)

The production method of a cyclized peptide according to claim 12, wherein the protecting group of the SH group of the completely-protected peptide is an acetamidomethyl group (Acm group), a t-butyl group (t-Bu group), a trityl group (Trt group), a benzyl group (Bzl group), a 4-methylbenzyl group (4-MeBzl group), or a 4-methoxybenzyl group (MBzl group).

### Claim 14 (depends on 11)

The production method of a cyclized peptide according to claim 11, wherein the temporary S—S formation is performed by an iodine treatment, a DMSO/TFA treatment, or a thallium (III) trifluoroacetate treatment.

### Claim 15 (depends on 14)

The production method of a cyclized peptide according to claim 14, wherein the temporary S—S formation is performed by an iodine treatment.

### Claim 16 (depends on 3)

The production method of a cyclized peptide according to claim 3, wherein the S-protected peptide is obtained by
a)
1) after removing the protecting groups of all functional groups other than the SH group in step (1-A),
2) removing the protecting group of the SH group, and further
3) carrying out temporary S—S formation in step (1-B) to obtain a temporary S—S formed peptide mixture, or
b)
1) after removing the protecting group of the SH group of the completely-protected peptide,
2) carrying out temporary S—S formation in step (1-B) to obtain a temporary S—S formed peptide mixture, and further
3) removing the protecting groups of all functional groups other than the SH group protected by temporary S—S bond formation in the temporary S—S formed peptide mixture in step (1-A).

### Claim 17 (depends on 16)

The production method of a cyclized peptide according to claim 16, wherein the protecting group of the SH group is a protecting group other than an S-type protecting group.

### Claim 18 (depends on 17)

The production method of a cyclized peptide according to claim 17, wherein the protecting group of the SH group is a phenylacetamidomethyl group (Phacm group), a 4-methoxybenzyl group (MBzl group), or a mono methoxytrityl group (MMTrt group).

### Claim 19 (depends on 18)

The production method of a cyclized peptide according to claim 18, wherein the protecting group of the SH group is removed by a treatment with an aqueous solution in the presence of penicillin amidohydrolase (PGA), a treatment with DDQ, or a treatment with a weak acid.

### Claim 20 (depends on 16)

The production method of a cyclized peptide according to claim 16, wherein the temporary S—S formation is performed by an iodine treatment, an Npys-OMe treatment, or a thallium (III) trifluoroacetate treatment.

### Claim 21 (depends on 20)

The production method of a cyclized peptide according to claim 20, wherein the temporary S—S formation is performed by an iodine treatment.

### Claim 22 (depends on 2)

The production method of a cyclized peptide according to claim 2, wherein the protection of all SH groups by forming a temporary S—S bond in step (1-B) is performed by forming a temporary S—S bond with an S-type protecting group.

### Claim 23 (depends on 22)

The production method of a cyclized peptide according to claim 22, wherein the protection of all SH groups by forming a temporary S—S bond in step (1-B) is performed by re-protecting the SH group with an S-type protecting group instead of a protecting group other than an S-type protecting group.

### Claim 24 (depends on 22)

The production method of a cyclized peptide according to claim 22, wherein the S-type protecting group is a 3-nitro-2-pyridinesulfenyl group (Npys group), a t-butylmercapto group (S-tBu group), or an ethylmercapto group (S-Et group).

### Claim 25 (depends on 22)

The production method of a cyclized peptide according to claim 22, wherein the S-protected peptide is obtained by re-protecting protecting groups of SH groups of a linear peptide having two or more SH groups as functional groups on the peptide, in which an N terminal amino group is optionally protected, and all of a C-terminal carboxy group and other functional groups on the peptide are protected, with an S-type protecting group, or
protecting same with an S-type protecting group in advance to obtain a peptide in which all SH groups are protected by formation of a temporary S—S bond with the S-type protecting group in step (1-B), and
removing the protecting groups of all functional groups other than the SH group protected by the temporary S—S bond in the peptide in step (1-A).

### Claim 26 (depends on 1)

The production method of a cyclized peptide according to claim 1, wherein the deprotection is performed in the absence of a reducing agent.

### Claim 27 (depends on 1)

The production method of a cyclized peptide according to claim 1, wherein the folding step under the oxidation and reduction conditions in step (2) is performed in an aqueous solution with pH 6 or higher.

### Claim 28 (depends on 1)

The production method of a cyclized peptide according to claim 1, wherein the folding step under the oxidation and reduction conditions in step (2) is performed in the co-presence of an oxidant and a reducing agent.

### Claim 29 (depends on 1)

The production method of a cyclized peptide according to claim 1, wherein the number of SH groups as the functional group on the peptide of the S-protected peptide is 2.

### Claim 30 (depends on 1)

The production method of a cyclized peptide according to claim 1, wherein the number of SH groups as the functional group on the peptide of the S-protected peptide is not less than 4.

### Claim 31 (depends on 1)

The production method of a cyclized peptide according to claim 1, wherein the number of SH groups as the functional group on the peptide of the S-protected peptide is an even number.
